Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE ( © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 February 2021

Abstract and Keywords

The purpose of this chapter is to review the literature concerning the psychopharmacology of personality disorders. We first review the double-blind placebo-controlled pharmacologic studies of all the personality disorders, except for borderline personality disorder (BPD). Attention is then focused on BPD. While there have been many open-labeled studies, there are fewer than 30 randomized-controlled trials even for this personality disorder. The section on borderline personality disorder will conclude with guidance as to how to think about the management of the actual pharmacologic treatment of this disorder, including matters such as dosage, lethality, augmentation, and avoiding polypharmacy. We conclude with a discussion of the obstacles hampering the development of a more substantial database that could provide guidance and direction.

Keywords: psychopharmacology, pharmacotherapy, polypharmacy, treatment, medication, personality disorders, borderline

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.